GenVoy™ Lipid Nanoparticles: A Versatile Tool for Developing RNA Vaccines

Time: 12:15 pm
day: Day One


  • Delving into successful development of an RNA-LNP: optimal RNA vector design, LNP delivery system and robust manufacturing process
  • Outlining a study where we demonstrate how an early vaccine development workflow can be accelerated from inception to early pre-clinical studies
  • Demonstrating how GenVoy-ILM™ together with the NanoAssemblr® Ignite™ can be used to optimize an RNA-LNP vaccine to illicit potent immune response against the target antigen